
Avacta Group, the developer of Affimer biotherapeutics and research reagents, has appointed Tony Gardiner as group chief financial officer. Gardiner …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

